Belite Bio (BLTE) Tops Q3 EPS by 22c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Buffalo Potash closes C$14M first tranche of private placement
• Buffalo Potash Announces Closing of C$14.01 Million First Tranche of Oversubscribed and Upsized C$14.85 Million Non-Brokered Private Placement